Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;5(6):e377.
doi: 10.1002/edm2.377. Epub 2022 Oct 12.

Visceral fat loss by whole-body electromyostimulation is attenuated in male and absent in female older Non-Insulin-Dependent diabetes patients

Affiliations

Visceral fat loss by whole-body electromyostimulation is attenuated in male and absent in female older Non-Insulin-Dependent diabetes patients

Alexander P J Houdijk et al. Endocrinol Diabetes Metab. 2022 Nov.

Abstract

Introduction: Type 2 diabetes and its reversal correlate with increases and decreases in visceral fat (VF). Resistance exercise reduces VF in healthy persons, but little is known in type 2 diabetes. Muscle contractions induced by whole-body electromyostimulation (WB-EMS) provide a very effective form of resistance training. We hypothesized that WB-EMS reduces VF and improves plasma glucose measures in older non-insulin dependent diabetes mellitus (NIDDM) males and females.

Methods: A four-arm age-matched case control study was done on WB-EMS twice a week in older NIDDM patients (27 males, 18 females) compared with controls (15 males, 15 females). VAT area (VAT, cm2 ), total fat mass (TFM, kg) and lean body mass (LBM, kg) were assessed by DEXA-scanning. HbA1c, fasting glucose and plasma lipoproteins were measured at baseline and after 4 months.

Results: Baseline control VAT was higher in males than females (140.5 ± 35.6 vs. 96.7 ± 42.3, p < .001). In NIDDM, VAT was higher with no significant sex difference (206.5 ± 65.0 vs. 186.5 ± 60.5). In controls, WBEMS reduced VAT in males and females to similar extent (-16.9% and -16.4%, p < .001 vs. baseline) and in preference to TFM (-9.2% and -3.6%) or body weight loss (-2.8 and -2.1%). In NIDDM, VF loss was attenuated in males (-7.3%, p < .01) but completely absent in females. WBEMS reduced HbA1c and cholesterol and increased HDL levels (all p < .05) only in male NIDDM CONCLUSIONS: WBEMS induced VF loss in healthy older males and females an effect strongly attenuated in male and completely absent in female NIDDM patients. This questions the effectiveness of muscle contraction-induced VF lipolysis in NIDDM. Sex differences may dictate the success of resistance training in NIDDM, a subject that needs to be addressed in future studies.

Keywords: Type 2 diabetes; electromyostimulation; visceral obesity.

PubMed Disclaimer

Conflict of interest statement

N.B., W.V., M.H. and M.Z. have no relevant conflict of interest. A.H. is co‐founder and CEO of Preventimed, a research start‐up company originating from a grant from the European Regional Development Fund focused on prevention and treating visceral obesity associated diseases.

Figures

FIGURE 1
FIGURE 1
Percentual decreases are shown for intragroup and intergroup changes. Male control; VAT vs. TFM p < .01, VAT vs. TBM p < .0001, TFM vs. TBM p < .001. Male NIDDM; VAT vs. TFM p < .001, VAT vs. TBM p < .0001, TFM vs. TBM p < .01. Female control; VAT vs. TFM p < .01, VAT vs. TBM p < .01. Male control vs. male NIDDM; VAT p < .001, TFM p = .01. Male NIDDM vs. female NIDDM; TBM p < .05, VAT p < .05. Female control vs. Female NIDDM; VAT p < .005.

References

    1. Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):1‐11. doi:10.1038/s41598-020-71908-9 - DOI - PMC - PubMed
    1. Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Phys Rev. 2013;93(1):359‐404. doi:10.1152/physrev.00033.2011 - DOI - PubMed
    1. Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol. 2019;9(1):1‐58. doi:10.1002/cphy.c170040 - DOI - PMC - PubMed
    1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793‐1801. doi:10.1172/JCI29069 - DOI - PMC - PubMed
    1. Ryo M, Funahashi T, Nakamura T, et al. Fat accumulation and obesity‐related cardiovascular risk factors in middle‐aged Japanese men and women. Intern Med. 2014;53(4):299‐305. doi:10.2169/internalmedicine.53.9476 - DOI - PubMed

Substances